Perforation predicts poor prognosis in patients with primary intestinal diffuse large B-cell lymphoma

Histopathology

Volumn 53, Issue 4, 2008, Pages 432-440

  Chuang, S S ^a,b,c   Ye, H ^d   Yang, S F ^e   Huang, W T ^f   Chen, H K ^f   Hsieh, P P ^g,h   Hwang, W S ^b   Chang, K Y ^i,j   Lu, C L ^b   Du, M Q ^d  

^a Chi Mei Foundation Hospital   (Taiwan)

^b CHI MEI FOUNDATION HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^g KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^h Yuh Ing Junior College of Health Care and Management   (Taiwan)

ⁱ NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^j NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

more..

Author keywords

Diffuse large B cell lymphoma; FISH; Immunophenotype; Intestine; Perforation; Taiwan

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; PREDNISOLONE; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CECUM; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; ILEUM; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTESTINE LYMPHOMA; INTESTINE PERFORATION; LARGE CELL LYMPHOMA; MALE; MULTIPLE CYCLE TREATMENT; PANCREATICODUODENECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TAIWAN; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GERMINAL CENTER; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INTESTINAL NEOPLASMS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PHENOTYPE; PROGNOSIS; SURVIVAL ANALYSIS; TRANSLOCATION, GENETIC;

EID: 52649096885     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03140.x     Document Type: Article

References (37)

1. Isaacson PG, Du MQ. Gastrointestinal lymphoma: where morphology meets molecular biology. J. Pathol. 2005 205 255 274.
2. Dragosics B, Bauer P, Radaszkiewicz T. Primary gastrointestinal non-Hodgkin's lymphomas. A retrospective clinicopathologic study of 150 cases. Cancer 1985 55 1060 1073.
3. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972 29 252 260.
4. Weingrad DN, Decosse JJ, Sherlock P, Straus D, Lieberman PH, Filippa DA. Primary gastrointestinal lymphoma: a 30-year review. Cancer 1982 49 1258 1265.
5. Zinzani PL, Magagnoli M, Pagliani G et al. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients. Haematologica 1997 82 305 308.
6. Almasri NM, al-Abbadi M, Rewaily E, Abulkhail A, Tarawneh MS. Primary gastrointestinal lymphomas in Jordan are similar to those in Western countries. Mod. Pathol. 1997 10 137 141.
7. Amer MH, el-Akkad S. Gastrointestinal lymphoma in adults: clinical features and management of 300 cases. Gastroenterology 1994 106 846 858.
8. Franssila KO, Jaser N, Sivula A. Gastrointestinal non-Hodgkin's lymphoma. A population-based clinicopathological study of 111 adult cases with a follow-up of 10-15 years. Apmis 1993 101 631 641.
9. Ruskone-Fourmestraux A, Aegerter P, Delmer A, Brousse N, Galian A, Rambaud JC. Primary digestive tract lymphoma: a prospective multicentric study of 91 patients Groupe d'Etude des Lymphomes Digestifs. Gastroenterology 1993 105 1662 1671.
10. Nakamura S, Matsumoto T, Takeshita M et al. A clinicopathologic study of primary small intestine lymphoma: prognostic significance of mucosa-associated lymphoid tissue-derived lymphoma. Cancer 2000 88 286 294.
11. Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000 403 503 511.
12. Rosenwald A, Wright G, Chan WC et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 2002 346 1937 1947.
13. Chang CC, McClintock S, Cleveland RP et al. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. Am. J. Surg. Pathol. 2004 28 464 470.
14. Hans CP, Weisenburger DD, Greiner TC et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004 103 275 282.
15. Connor J, Ashton-Key M. Gastric and intestinal diffuse large B-cell lymphomas are clinically and immunophenotypically different. An immunohistochemical and clinical study. Histopathology 2007 51 697 703.
16. Daum S, Ullrich R, Heise W et al. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. J. Clin. Oncol. 2003 21 2740 2746.
17. Krugmann J, Dirnhofer S, Gschwendtner A et al. Primary gastrointestinal B-cell lymphoma. A clincopathological and immunohistochemical study of 61 cases with an evaluation of prognostic parameters. Pathol. Res. Pract. 2001 197 385 393.
18. Go JH, Yang WI, Ree HJ. CD10 expression in primary intestinal large B-cell lymphomas: its clinical significance. Arch. Pathol. Lab. Med. 2002 126 956 960.
19. Kramer MHH, Wijburg HE, Geelen KPE et al. Clinical relevance of BCL2, BCL6, and MYC rearrangemens in diffuse large B-cell lymphoma. Blood 1998 92 3152 3162.
20. Yoshida N, Nomura K, Wakabayashi N et al. Cytogenetic and clinicopathological characterization by fluorescent in situ hybridisation on paraffin-embedded tissue sections of twenty-six cases with malignant lymphoma of small intestine. Scand. J. Gastroenterol. 2006 41 212 222.
21. Greene FL, Page DL, Fleming ID et al. eds. Lymphoid neoplasms. In AJCC cancer staging manual, 6th edn. New York: Springer, 2002 393 406.
22. Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. In Jaffe ES, Harris NL, Stein H et al. eds. World Health Organization classification of tumours: tumours of the haematopoietic and lymphoid tissue. Lyon: IARC Press, 2001 171 174.
23. Pileri SA, Dirnhofer S, Went P et al. Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification Histopathology 2002 41 482 509.
24. Martin-Subero JI, Chudoba I, Harder L et al. Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses. Am. J. Pathol. 2002 161 413 420.
25. Rohatiner A, d'Amore F, Coiffier B et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann. Oncol. 1994 5 397 400.
26. de Leval L, Harris NL. Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance. Histopathology 2003 43 509 528.
27. Hill ME, MacLennan KA, Cunningham DC et al. Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study. Blood 1996 88 1046 1051.
28. Hermine O, Haioun C, Lepage E et al. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma Groupe d'Etude des Lymphomes de l'Adulte (GELA). Blood 1996 87 265 272.
29. Lin CH, Kuo KT, Chuang SS et al. Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin. Clin. Cancer Res. 2006 12 1152 1156.
30. Prescarmona E, De Sanctis V, Pistilli A et al. Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas. J. Pathol. 1997 183 281 286.
31. Vitolo U, Gaidano G, Botto B et al. Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients. Ann. Oncol. 1998 6 55 61.
32. Barrans SL, Evans PAS, O'Connor SJM et al. The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome. Clin. Cancer Res. 2003 9 2133 2139.
33. Nakamura S, Ye H, Bacon CM et al. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma. Clin. Cancer Res. 2008 14 3002 3010.
34. Offit K, Lo Coco F, Louie DC et al. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N. Engl. J. Med. 1994 331 74 80.
35. Akasaka T, Akasaka H, Ueda C et al. Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene. J. Clin. Oncol. 2000 18 510 518.
36. Kadar N, Homesley HD, Malfetano JH. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol. Oncol. 1992 46 145 149.
37. Kashimura M, Sugihara K, Toki N et al. The significance of peritoneal cytology in uterine cervix and endometrial cancer. Gynecol. Oncol. 1997 67 285 290.